您当前的位置：
首页 >
文章列表页 >
The diagnostic value of molecular imaging in treatment-related cardiotoxicity of malignancy
更新时间：2025-12-15

    • The diagnostic value of molecular imaging in treatment-related cardiotoxicity of malignancy

    • “New progress in the diagnosis of cardiac toxicity in the treatment of malignant tumors, with the assistance of nuclear medicine molecular imaging technology for early identification.”
    • Oncoradiology   Vol. 34, Issue 1, Pages: 24-29(2025)

    • DOI：10.19732/j.cnki.2096-6210.2025.01.004    

      CLC：

    • Received：22 January 2025，

      Published Online：13 March 2025，

      Published：28 February 2025

    移动端阅览

  • Xu ZHAO, Xuezhi LIN, Guojian ZHANG. The diagnostic value of molecular imaging in treatment-related cardiotoxicity of malignancy[J]. Oncoradiology, 2025, 34(1): 24-29. DOI： 10.19732/j.cnki.2096-6210.2025.01.004.

  •  
  •  

0

Views

297

下载量

0

CNKI被引量

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Advances in FAP-targeted molecular imaging probes for disease detection
Nuclear medicine and molecular imaging of T cell effector function: toward precision immunotherapy of cancer
FAPI in radionuclide theranostics: toward a new emerging paradigm for tumor management
Annual progress in ultrasound clinical research on liver diseases in China in 2024
Contrast-enhanced ultrasound for the diagnosis of intrahepatic cholangiocarcinoma: debates, focus areas and emerging perspectives

Related Author

WANG Xiao
XU Xiaoping
SONG Shaoli
ZHOU Haoyi
LIU Zhaofei
Ying DING
Hui YANG
Hong HAN

Related Institution

Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University
Medical Isotopes Research Center, Department of Radiation Medicine, School of Basic Medical Sciences, Peking University Health Science Center
Department of Nuclear Medicine, Peking University Cancer Hospital and Institute
Department of Nuclear Medicine, Peking University Third Hospital
Key Laboratory of Precision Diagnosis and Treatment in Oncology Nuclear Medicine for Henan Provincial
0